Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will ...

In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) ...

Every bladder cancer journey is different, and no single treatment or diagnostic path fits everyone. According to patients who have experienced bladder cancer, the best care for you will depend on ...

A groundbreaking new therapy for ovarian cancer is being trialled on a Brisbane woman, in an Australian-first, which aims to ...

DNA profiling can help stratify risk of recurrence in patients with BCG-unresponsive NMIBC treated with atezolizumab. Read ...

Discover a study comparing ultrasound and CBCT for bladder monitoring in prostate cancer radiotherapy to improve accuracy and ...

Joseph Jacob, MD, discusses the promising impact of TAR-200.

The FDA designates the TOBY Test as a breakthrough device, revolutionizing bladder cancer detection with a non-invasive, ...

Beat bladder cancer with early detection! Expert insights reveal how a multidisciplinary approach can improve treatment ...

ImmunityBio, Inc. (NASDAQ: IBRX) today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has ...

AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer: Cambridge, UK Saturday, July 5, 2025, 09:00 Hrs [IST] AstraZen ...